BR112014005011A2 - compound, treatment methods and pharmaceutical composition - Google Patents
compound, treatment methods and pharmaceutical compositionInfo
- Publication number
- BR112014005011A2 BR112014005011A2 BR112014005011A BR112014005011A BR112014005011A2 BR 112014005011 A2 BR112014005011 A2 BR 112014005011A2 BR 112014005011 A BR112014005011 A BR 112014005011A BR 112014005011 A BR112014005011 A BR 112014005011A BR 112014005011 A2 BR112014005011 A2 BR 112014005011A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- treatment methods
- treatment
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/18—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161529942P | 2011-09-01 | 2011-09-01 | |
PCT/EP2012/066721 WO2013030205A1 (en) | 2011-09-01 | 2012-08-29 | Parp inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014005011A2 true BR112014005011A2 (en) | 2017-05-30 |
Family
ID=46796563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014005011A BR112014005011A2 (en) | 2011-09-01 | 2012-08-29 | compound, treatment methods and pharmaceutical composition |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2758370A1 (en) |
JP (1) | JP2014531416A (en) |
KR (1) | KR20140062096A (en) |
CN (1) | CN103906730A (en) |
BR (1) | BR112014005011A2 (en) |
CA (1) | CA2846429A1 (en) |
MX (1) | MX2014002343A (en) |
RU (1) | RU2014110624A (en) |
WO (1) | WO2013030205A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5441864A (en) * | 1977-09-02 | 1979-04-03 | Sankyo Co Ltd | Beta-lactam homolog and its preparation |
US7642277B2 (en) * | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
WO2007144652A2 (en) * | 2006-06-15 | 2007-12-21 | Kudos Pharmaceuticals Limited | Parp inhibitors |
WO2010139966A1 (en) * | 2009-06-05 | 2010-12-09 | Oslo University Hospital Hf | Azole derivatives as wtn pathway inhibitors |
-
2012
- 2012-08-29 KR KR1020147008487A patent/KR20140062096A/en not_active Application Discontinuation
- 2012-08-29 BR BR112014005011A patent/BR112014005011A2/en not_active Application Discontinuation
- 2012-08-29 MX MX2014002343A patent/MX2014002343A/en unknown
- 2012-08-29 CN CN201280053428.1A patent/CN103906730A/en active Pending
- 2012-08-29 CA CA2846429A patent/CA2846429A1/en not_active Abandoned
- 2012-08-29 JP JP2014527633A patent/JP2014531416A/en active Pending
- 2012-08-29 WO PCT/EP2012/066721 patent/WO2013030205A1/en active Application Filing
- 2012-08-29 RU RU2014110624/04A patent/RU2014110624A/en not_active Application Discontinuation
- 2012-08-29 EP EP12753948.4A patent/EP2758370A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
RU2014110624A (en) | 2015-10-10 |
MX2014002343A (en) | 2014-04-30 |
CN103906730A (en) | 2014-07-02 |
JP2014531416A (en) | 2014-11-27 |
EP2758370A1 (en) | 2014-07-30 |
CA2846429A1 (en) | 2013-03-07 |
KR20140062096A (en) | 2014-05-22 |
WO2013030205A1 (en) | 2013-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015002738A2 (en) | compound and pharmaceutical composition | |
BR112014002621A2 (en) | antibody, pharmaceutical composition, pharmaceutical combination, DNA and treatment method | |
BR112013033811A2 (en) | composition, method of preparing the composition, and | |
DK2694038T3 (en) | PHARMACEUTICAL COMPOSITION | |
BR112012022879A2 (en) | compound, pharmaceutical composition, compound use and treatment method | |
BR112014023937A2 (en) | pharmaceutical composition, pharmaceutical combination and treatment method | |
PL2672966T3 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
BR112012022878A2 (en) | compound, pharmaceutical composition, compound use and method of treatment | |
BR112013010725A2 (en) | Method and composition | |
RS61827B1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
BR112015003259A2 (en) | compound, pharmaceutical composition, and vaccine composition. | |
BR112014004192A2 (en) | seed treatment composition and seed treatment method | |
BR112014010290A2 (en) | pharmaceutical composition, methods, compositions and uses | |
BR112014007203A2 (en) | compound, pharmaceutical composition, method of treatment, use of a compound, assembly and invention | |
BR112013014644A2 (en) | pharmaceutical composition and complex | |
BR112014009889A2 (en) | disubstituted compounds, compounds and pharmaceutical composition | |
ITTO20110641A1 (en) | PHARMACEUTICAL COMPOSITIONS AND TREATMENT METHODS | |
BR112014009950A2 (en) | disubstituted compound, compounds and pharmaceutical composition | |
BR112013019327A2 (en) | compound and composition. | |
BR112013022820A2 (en) | treatment method | |
BR112013022306A2 (en) | Method and composition | |
BR112014003556A2 (en) | virus treatment method and pharmaceutical composition | |
CO6811865A2 (en) | Dengue fever treatment method | |
BR112014012759A2 (en) | compound, composition and method for treatment | |
BR112013019224A2 (en) | composition, and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |